MLEC (Moolec Science) Cyclically Adjusted PS Ratio: (As of Jul. 06, 2026)


MLEC Moolec Science SA MLEC
44 GF Score
Price $8.00
GF Value $84.84
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Moolec Science Cyclically Adjusted PS Ratio?

Moolec Science does not have a history long enough to calculate Cyclically Adjusted Revenue per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PS Ratio for this company.

Shiller PE for Stocks: The True Measure of Stock Valuation

Moolec Science  (NAS:MLEC) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.

Moolec Science Cyclically Adjusted PS Ratio Related Terms

Moolec Science Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Moolec Science's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moolec Science Cyclically Adjusted PS Ratio Chart

Moolec Science Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted PS Ratio
0.00 0.00 0.00 0.00 0.00

Moolec Science Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MLEC vs GNPX, ADIL, APVO: Cyclically Adjusted PS Ratio Comparison

For the Biotechnology subindustry, Moolec Science's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moolec Science Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moolec Science's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Moolec Science's Cyclically Adjusted PS Ratio falls into.


MLEC
44GF Score
Moolec Science SA MLEC
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Moolec Science Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Moolec Science does not have a history long enough to calculate Cyclically Adjusted Revenue per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PS Ratio for this company.

Is Moolec Science (MLEC) Overvalued in 2026?

Based on GuruFocus' analysis, Moolec Science stock appears to be undervalued. The current stock price of $8.00 is trading 90.6% below its estimated GF Value™ of $84.84. GuruFocus considers Moolec Science to be Possible Value Trap.

Key valuation signals for MLEC:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $84.84 vs. price of $8.00 (90.6% below fair value)
  • GF Score™: 44/100 with 9 warning signs

No single metric tells the full story. See the MLEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Moolec Science Business Description

Address c/o Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman, CYM, KY1-9009
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
44GF Score

Get the complete analysis for MLEC

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.00
Price
$84.84
GF Value